Posters
Glomerular Diseases: Management, Evolving Strategies, and Practice-Changing Advances
October 24, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Belimumab for Advanced Lupus Nephritis (CKD Stages 3-5): Efficacy and Safety from a Real-World Cohort
Allogeneic CD19 Synthetic T-Cell Receptor (STAR-T) Without Lymphodepletion for Refractory Lupus Nephritis: First-in-Human Result
Development and Validation of a Lectin-Based Assay for the Detection of IgG Fc Glycosylation as a Biomarker in Lupus Nephritis
Long-Term Use of Voclosporin as Rescue Therapy in Patients with Lupus Nephritis
Myddosome Expression and Kidney Response in Lupus Nephritis: A Longitudinal Study
Kidney Response to CD19+ Chimeric Antigen Receptor (CAR)-T Cell Treatment of Refractory Systemic Lupus Erythematosus
Off-the-Shelf Dual-Targeted Synthetic T-Cell Receptor (STAR-T) for Autoimmune Kidney Diseases: Preclinical Proof of Concept and First Clinical Experience
Kidney Outcomes in Patients with Systemic Lupus Erythematosus (SLE) Receiving Anifrolumab in the ASTER Real-World Study
Clinical Phenotypes and Histopathological Diversity of Lupus Nephritis: A Cross-Sectional Analysis from a Tertiary Center in Northeast India
Burden of Lupus Nephritis in Latin America: A Disability-Adjusted Life Years Analysis
Lupus Anticoagulant Positivity Is Associated with Reduced Renal Remission in Male Patients with Lupus Nephritis
Systemic Lupus Erythematosus Coexisting with IgAN: Case Series and Literature Review
Association of Lupus Nephritis Histologic Class with Serologic Markers and 12-Month Outcomes
Value of Repeat Biopsy in Patients with Lupus Nephritis and No Remission Compared with Those Achieving Complete or Partial Remission
Histological Predictors of Treatment Response in Lupus Nephritis: Review of Immunofluorescence and Electron Microscopy Findings
Differences in Efficacy Between Two Ultrasound-Guided Percutaneous Kidney Biopsy Techniques at a Tertiary-Care Hospital in Mexico City
Histopathologic Patterns in Kidney Biopsies from Patients with Type 2 Diabetes at a Mexican Center
Clinicopathological Features and Kidney Outcomes of Biopsy-Proven Monoclonal Gammopathy-Associated Kidney Disease: A Single-Center Case Series
C1q Nephropathy in Saudi Cohort: Clinical Presentation, Histology, and Long-Term Outcomes
Clinicopathologic Comparison of Fibrillary Glomerulonephritis and AL Amyloidosis: A Single-Center Experience
Glomerular CR1 Expression Is Associated with Disease Severity and, When Combined with C4b Deposition, Improves Risk Stratification in IgAN
Association Between Percentage Decline in Proteinuria and Outcomes: Results from PARASOL FSGS
Mortality in Children and Adults with Glomerular Diseases in the CureGN Study
Urinary Extracellular Vesicle Multi-Omics via Epigallocatechin Gallate (EGCG)-Based Automated Enrichment Identifies Protein and miRNA Biomarkers Discriminating IgAN and ESRD
Comparison of Efficacy and Safety Among Four Therapeutic Regimens in Primary Membranous Nephropathy with High Phospholipase A2 Receptor (PLA2R) Antibody Titers: A Single-Center Retrospective Cohort Study
Spectrum of Nondiabetic Kidney Disease in Patients with Biopsy-Proven Diabetic Nephropathy: A 10-Year Single-Center Study
Development of a Predictive Model for Monoclonal Gammopathy of Renal Significance: A Retrospective Cohort Study from Northwest China
Urinary Lactate as a Prognostic Biomarker for Kidney Function Deterioration in Diabetic Kidney Disease
Association of Community Respiratory Viral Infections with Nephrotic Syndrome Relapse in Pediatric Patients
Baseline Selectivity Index Predicts Risk of Relapse After Complete Remission in Patients with Primary Membranous Nephropathy
Natural History and Post-Transplant Outcomes Among Patients with Kidney Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis
Glomerular Disease Outcomes in Asian Americans in CureGN/NEPTUNE
Long-Term Kidney Outcomes and Prognostic Determinants in Pure Class V Lupus Nephritis
Development of a Prototype Bridge Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Nephrin Autoantibodies
Crescent Burden and Rapidly Progressive Glomerulonephritis Predict Kidney Survival in Patients with Lupus Nephritis: A Latin American Cohort
Clinicopathologic Features and Kidney Outcomes in Primary Antiphospholipid Syndrome-Associated Nephropathy
Switching from Dual to Single Renin-Angiotensin System Blockade Plus SGLT2 Inhibitors in Patients with Chronic Glomerular Diseases
Clinicopathologic Phenotypes Across Native Kidney Biopsy Diagnoses: A Mexican Cohort Study
Centrifuge vs. Filter Separation: Which Is the Best Variant for Plasma Exchange in ANCA-Associated Vasculitis? A Post Hoc Analysis of the PEXIVAS Trial
Plasma Proteomic Endotypes Refine Diagnosis and Risk Assessment Across Primary Glomerular Diseases
Single-Nucleus Kidney Biopsy Profiling Defines Transport Reserve, Fibroinflammatory Remodeling, and Disease-Residual Molecular Patient States Across the Spectrum of Primary Glomerular Diseases
Seroprotection After Influenza Vaccination in Patients with Glomerular Diseases
Network Meta-Analysis of Triple Immunosuppressive Therapies and Standard of Care for Induction of Remission of Active Lupus Nephritis
Proteinuria Reduction with SGLT2 Inhibitor Therapy for Lupus Nephritis: A Systematic Review and Single-Arm Meta-Analysis
Integrating Vascular Injury into Risk Prediction: Renal Thrombotic Microangiopathy in Lupus Nephritis Outcomes
Exploratory Protein Biomarkers and Urinary Extracellular Vesicle microRNA Changes After TRPC6 Inhibition with Apecotrep in FSGS
A Single-Center Study Using Cell-Based Indirect Immunofluorescence to Detect Nephrin Autoantibodies Across Subtypes of Nephrotic Syndrome in Children
Specialty and Phenotype Patterns in Biologic- and Calcineurin Inhibitor (CNI)-Based Combination Therapy for Lupus Nephritis
Timing and Patterns of Diagnosis in Glomerular Kidney Diseases
A Randomised Controlled Trial of Tripterygium wilfordii Polyglycoside in the Long-Term Treatment of Stage 4 Diabetic Nephropathy
Kidney Biopsy in Patients with Diabetes: A 30-Year Single-Center Study
Direct Oral Anticoagulants vs. Standard of Care in Nephrotic Syndrome
Assessing Proteinuria as a Mediator of Treatment Effects of Calcineurin Inhibitors (CNI) vs. Rituximab (RTX) for Membranous Nephropathy (MN)
Complications and Risk Factors After Native Kidney Biopsy in Patients with Reduced Kidney Function
ADX-038, a Potent Complement Factor B siRNA, Provides Deep and Prolonged Inhibition of the Alternative Pathway
Real-World Use and Clinical Outcomes with Sparsentan in the United Kingdom (UK) and Germany
Therapeutic Plasma Exchange Use After PEXIVAS in Hospitalized Adults with ANCA-Associated Vasculitis
Emerging Monoclonal Therapies for Nephrotic Syndrome: A Systematic Review of Native and Post-Transplant Disease
Artificial Intelligence (AI) Chatbots and Nephrologists' Reasoning Across Standardized Nephrology Case Vignettes
Clinical Features, Histopathology, and Outcomes of Fibrillary Glomerulonephritis: A Spanish Multicenter Cohort
Renoprotective Effects of Direct Oral Anticoagulants in Glomerular Diseases